What are some recent advancements in proteomics-driven pancreatic oncology research?

FHS
August 9, 2023
10:31 am

The application of proteomics-driven biomarkers for early detection, diagnosis, and treatment of pancreatic cancer.

Researchers introduce CRISPR-mediated genome and cancer shredding as a conceptual paradigm to treat recurrent gliomas

Researchers demonstrated clustered regularly interspersed short palindromic repeats (CRISPR)-mediated elimination of glioblastoma (GBM) cells.

November 29, 2023

NHS to offer MSD’s belzutifan for von Hippel-Lindau disease

The treatment is intended to be administered orally three times a day to simultaneously target three different types of tumours. Credit: Pormezz/Shutterstock. The National Health

September 5, 2024

BioNTech eases 2024 revenue outlook despite hefty Covid vaccine third-quarter sales

Despite strong third-quarter revenues, BioNTech has softened its 2024 sales guidance in light of changes to Covid-19 vaccine uptake, pricing and seasonal variations. The company

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.